苯并恶唑|Benzoxazoles-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

苯并恶唑是一种芳香族有机化合物，分子式为C7H5NO，苯并恶唑环结构，气味类似于吡啶。[1][2]虽然苯并恶唑本身没有多少实用价值，但许多苯并恶唑衍生物在商业上是重要的。作为杂环化合物，苯并恶唑作为合成更大、通常是生物活性结构的起始材料在研究中得到应用。它的芳香性使其相对稳定，虽然作为杂环，它具有活性位点，使其能够官能化。

按化学元素: B^x; C^x; N^x; O^x; F^x; Si^x; P^x; S^x; Cl^x; Br^x; I^x

官能团： 芳基 (7) 溴代物 (5) 胺 (1) 酰胺 (3) 羧酸 (3) 含氟砌块 (1) 苯硫酚 (1) 氯代物 (6) 酯 (2) 硝基 (2) 硫化物 (1) 更多

母核：

按纯度： 99+% 99% 98+% 98% 97+% 97% 96+% 96% 95+% 95% 93% 90+% 90%

按分子量： 100-200 200-300 300-400 400-500 500-600 600-700 800-900

按化学元素： CINO CNOP CClFNO CBrClNOS CINOS CNNaO CBrNO CBClFNO CClNOS CClNOPS CFINO CBBrNO CNO CBrFNOS CNOS CFNOS CClNNaOS CClFNOS CClNNaO CBrNOS CClINO CClINOS CBrClNO CClNO CBrFNO CNNaOS CBClNO CBrClFNO CFNO CBNO CBrINO 更多

7-Bromo-2-(3-fluoro-4-methoxyphenyl)-5-methoxybenzo[d]oxazole 7-溴-2-(3-氟-4-甲氧基苯基)-5-甲氧基苯并[d]恶唑: BJS7173963544704-75-898%; ￥5500.00250mg

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazole 2-(4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)苯基)苯并[d]恶唑: BJS0939246439090-73-095%; ￥443.00250mg

2-(Benzo[d]oxazol-2-yl)phenol 2-(2-羟基苯基)苯并恶唑: BJS6828354835-64-395%; ￥395.005g

2-Phenylbenzo[d]oxazole 2-苯基苯并[d]恶唑: BJS9827450833-50-198%; ￥141.001g

6-Iodobenzo[d]oxazol-2(3H)-one 6-碘苯并[d]恶唑-2(3H)-酮: BJS346112319932-87-795%; ￥6014.005g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2-amine 5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯并[d]恶唑-2-胺: BJS11662091224844-66-997+%; ￥6359.001g

2-(p-Tolyl)benzo[d]oxazole 2-(对甲苯基)苯并[d]恶唑: BJS4434863835-71-295%; ￥533.00250mg

7-Chlorobenzo[d]oxazol-2-amine 7-氯苯并[d]恶唑-2-胺: BJS215688364037-11-295%; ￥12018.005g

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]oxazol-2-amine N-(4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯基)苯并[d]恶唑-2-胺: BJS5531000330793-73-295+%; ￥5000.001g

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole 2-甲基-6-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯并[d]恶唑: BJS57220951408089-23-595%; ￥218.00100mg

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole 2-甲基苯并噁唑-5-硼酸频那醇酯: BJS2642235845872-30-297%; ￥378.00250mg

5-(Bromomethyl)benzo[d]oxazole 5-(溴甲基)苯并[d]噁唑: BJS8928214181038-98-297%; ￥4967.001g

4-Nitrobenzo[d]oxazol-2(3H)-one 4-硝基苯并[d]恶唑-2(3H)-酮: BJS203146528955-71-798%; ￥1615.001g

2-(tert-Butyl)benzo[d]oxazole 2-(叔丁基)苯并[d]恶唑: BJS627948654696-03-695%; ￥2743.00250mg

1-(4-(Benzo[d]oxazol-2-yl)piperidin-1-yl)-2-chloroethan-1-one 1-(4-(苯并[d]恶唑-2-基)哌啶-1-基)-2-氯乙酮: BJS8589212851288-56-795%; ￥1882.00100mg

1-(Benzo[d]oxazol-2-yl)-2-phenylethan-1-amine hydrochloride 1-(苯并[d]恶唑-2-基)-2-苯基乙胺盐酸盐: BJS94565001955515-69-195%; ￥2430.00250mg

2-(tert-Butyl)benzo[d]oxazol-6-amine 2-(叔丁基)苯并[d]恶唑-6-胺: BJS86235601152527-60-097%; ￥1976.0050mg

3-(Furan-2-yl)-N-(2-(pyridin-4-yl)benzo[d]oxazol-5-yl)acrylamide 3-(呋喃-2-基)-N-(2-(吡啶-4-基)苯并[d]恶唑-5-基)丙烯酰胺: BJS9489615332063-87-398%; ￥2602.0050mg

4-(Benzo[d]oxazol-2-yl)-N-phenylaniline 4-(苯并[d]恶唑-2-基)-N-苯基苯胺: BJS25497801643848-13-899% HPLC; ￥6279.001g

N-(4-((4-(Benzo[d]oxazol-2-yl)phenyl)carbamoyl)phenyl)benzofuran-2-carboxamide N-(4-((4-(苯并[d]恶唑-2-基)苯基)氨基甲酰基)苯基)苯并呋喃-2-甲酰胺: BJS7334068423148-46-395%; ￥32760.00100mg

1 2 3 4 5 6 7 8 9 ... 17